Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers
A commentary on the original research article: ‘Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers’. Of note, the predictor selection process, the cross-validation method, along with the lack of final testing of the developed model with a separated data s...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2021-07-01
|
| Col·lecció: | Journal for ImmunoTherapy of Cancer |
| Accés en línia: | https://jitc.bmj.com/content/9/7/e003044.full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|